Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment — immunotherapy — may help change the environment where cancer cells live, possibly helping the immune system respond more effectively.

A precise timing of existing treatments could significantly improve treatment outcomes for one of the most aggressive cancers, suggests new research from researchers at UC San Diego.

This editorial reviews Decker et al’s study of more than 100,000 veterans experiencing homelessness who were overdue for colorectal or breast cancer screening. About 57,000 secured housing during a 24-month window and were more than twice as likely to get screened after doing so. 

The brain’s health depends on more than just its neurons. A complex network of blood vessels and immune cells acts as the brain’s dedicated guardians—controlling what enters, cleaning up waste, and protecting it from threats by forming the blood-brain barrier. A new study from Gladstone Institutes reveals that many genetic risk factors for neurological diseases like Alzheimer’s and stroke exert their effects within these very guardian cells.